These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 33684466

  • 1. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A, Srinivasarao S, Khetmalis YM, Kumar BK, Murugesan S, Shetye G, Ma R, Franzblau SG, Sekhar KVGC.
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A, Srinivasarao S, Agnieszka N, Ewa AK, Alvala M, Lherbet C, Chandra Sekhar KVG.
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against Mycobacterium tuberculosis.
    Nandikolla A, Khetmalis YM, Venkata Siva Kumar B, Chandu A, Karan Kumar B, Shetye G, Ma R, Murugesan S, Franzblau SG, Chandra Sekhar KVG.
    RSC Med Chem; 2023 Aug 16; 14(8):1549-1561. PubMed ID: 37593576
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and structure-activity studies of side chain analogues of the anti-tubercular agent, Q203.
    Kang S, Kim YM, Kim RY, Seo MJ, No Z, Nam K, Kim S, Kim J.
    Eur J Med Chem; 2017 Jan 05; 125():807-815. PubMed ID: 27750198
    [Abstract] [Full Text] [Related]

  • 6. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC, Oliver AG, Markley LD, Cho S, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2014 Aug 01; 24(15):3493-8. PubMed ID: 24909079
    [Abstract] [Full Text] [Related]

  • 7. Synthesis, molecular docking and anti-mycobacterial evaluation of new imidazo[1,2-a]pyridine-2-carboxamide derivatives.
    Jose G, Suresha Kumara TH, Nagendrappa G, Sowmya HB, Sriram D, Yogeeswari P, Sridevi JP, Guru Row TN, Hosamani AA, Sujan Ganapathy PS, Chandrika N, Narendra LV.
    Eur J Med Chem; 2015 Jan 07; 89():616-27. PubMed ID: 25462270
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
    Nagesh HN, Naidu KM, Rao DH, Sridevi JP, Sriram D, Yogeeswari P, Chandra Sekhar KV.
    Bioorg Med Chem Lett; 2013 Dec 15; 23(24):6805-10. PubMed ID: 24169232
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Seeking potent anti-tubercular agents: Design, synthesis, anti-tubercular activity and docking study of various ((triazoles/indole)-piperazin-1-yl/1,4-diazepan-1-yl)benzo[d]isoxazole derivatives.
    Naidu KM, Srinivasarao S, Agnieszka N, Ewa AK, Kumar MM, Chandra Sekhar KV.
    Bioorg Med Chem Lett; 2016 May 01; 26(9):2245-50. PubMed ID: 27020525
    [Abstract] [Full Text] [Related]

  • 13. 3-Aryl-substituted imidazo[1,2-a]pyridines as antituberculosis agents.
    Karale UB, Shinde AU, Babar DA, Sangu KG, Vagolu SK, Eruva VK, Jadav SS, Misra S, Dharmarajan S, Rode HB.
    Arch Pharm (Weinheim); 2021 Oct 01; 354(10):e2000419. PubMed ID: 34185337
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and evaluation of 1,2,3-triazole-adamantylacetamide hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Addla D, Jallapally A, Gurram D, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2014 Apr 15; 24(8):1974-9. PubMed ID: 24679703
    [Abstract] [Full Text] [Related]

  • 15. 2-Butyl-4-chloroimidazole based substituted piperazine-thiosemicarbazone hybrids as potent inhibitors of Mycobacterium tuberculosis.
    Jallapally A, Addla D, Yogeeswari P, Sriram D, Kantevari S.
    Bioorg Med Chem Lett; 2014 Dec 01; 24(23):5520-4. PubMed ID: 25451998
    [Abstract] [Full Text] [Related]

  • 16. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW, Tiwari R, Miller PA, Cho S, Franzblau SG, Miller MJ.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):2068-71. PubMed ID: 26951749
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Synthesis, In silico Molecular Docking and Pharmacokinetic Studies, In vitro Antimycobacterial and Antimicrobial Studies of New Imidozolones Clubbed with Thiazolidinedione.
    Khan IH, Patel NB, Patel VM.
    Curr Comput Aided Drug Des; 2018 Apr 15; 14(4):269-283. PubMed ID: 29766819
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.